Thank you very much, Joe and good afternoon everyone. Let me start by reviewing the key commercial activities in each segment in the second quarter. Plant-based segment revenues were down 8% year-over-year to a $114 million. Relative to our expectations, revenue was off approximately $15 million and was driven by two factors; one, the timing of new business; and two, category-influenced national brand performance. The timing of new business was affected by a number of frustratingly unrelated factors, including slow customer setup, slow transition from existing suppliers to SunOpta, and significant, albeit temporary, supply chain related disruptions at one of our tea customers. Track channel data for plant-based milks in Q2 showed softness throughout the quarter with sales up 1% and volume down 8% and performance in shelf stable was slightly worse. Track channel data reports oat milk sales grew 9% on flat volume with almond milk sales down 3% on 10% lower volumes. SunOpta total plant-based milk results across all channels were up 1% on 9% lower volumes. Oat milk sales grew 59% including a 58% increase in volume, and oat creamer sales were up 27% on double-digit volume growth. Largely offsetting the growth in oat was almond milk, which included the one-time revenue overlap we called out in Q2 of last year. As Joe mentioned, removing this overlap, packaged plant-based milk sales grew 10%. Looking at our business by customer, as you'd expect, results were mixed in Q2. Three of our top five customers delivered growth including two with double-digit gains, aided by the strength of our oat-based offerings. As mentioned, we have increased share with three of our top five customers, most of which will begin later in 2023 and into 2024. Looking at results on a go-to-market basis, owned brands remain the top performing area with sales up 27% versus last year, driven by equally strong growth in both Dream and SOWN. Private label also had a solid quarter of high single-digit growth, reflecting gains in non-dairy with major retail customers. The decline in our co-man business more than offset growth in owned brands and private label, reflecting softness in the category and the timing overlap in almond milk. Similar to Q1, our ingredients business was down for the reasons that we outlined on the Q1 call. Importantly, we have completed the restaging of oat-based to finished goods at the end of Q2. We continue to ramp production at our Texas facility including our new 330 milliliter protein shake line. This facility gives us sufficient capacity to reach our goal of doubling the plant-based business off of the 2020 base, along with enhanced capabilities and providing a strategically advantaged location for many of our current and new customers. Moving to our fruit-based segment. Snacks continued to be the key story. Fruit snacks sales were up nearly 14%, driven primarily by volume growth, reflecting strong underlying trends in consumption as well as the strength of our platform to support innovation and provide incremental capacity to our customers. More than offsetting the growth in fruit snacks with softness in our frozen business, which was down 10% due to supply constraints, together with unfavorable consumption trends that negatively impacted retail volumes and food service orders, along with the recall in June. Overall, our fruit-based segment revenues were down 4% in the second quarter versus last year, mostly driven by frozen volume. We could continue to have a significant pipeline of potential growth opportunities in our snack business and look forward to the additional capacity coming online here in third quarter, which will provide headroom to grow this business by another 40% over time. Now, let me walk through the more detailed financial results in the quarter. Second quarter revenues of $208 million were down 6% versus last year, adjusted for the divestiture of the Sunflower business. Adjusted gross profit removing startup and recall costs was $25.3 million or 12.1% of revenue down $7 million versus last year on a like-for-like basis, reflecting lower volumes. In plant-based, segment level gross margin was 12.6% as reported, and adjusted for startup costs in Texas was 17.5%, a 90 basis point improvement over the prior year period. In fruit-based, segment level gross margin as reported was 2.1% and adjusted for the frozen fruit recall was 5.5%, a 570 basis point decline versus last year. The margin decline was driven almost entirely by our frozen fruit business, principally impacted by an unfavorable sales mix and a stronger Mexican peso. You can see on the face of the P&L, a $2.4 million FX gain, while the effect of the higher cost inventory for Mexico reduces gross profit. I also want to provide a few comments on the voluntary frozen fruit recall we initiated in June. Specifically, we issued out of an abundance of caution, a voluntary recall of specific frozen fruit products linked to pineapple provided by a third-party supplier. As you would expect, we have permanently terminated our relationship with that supplier. From a financial perspective, we have insurance for this event in our Q2 results, reflecting net $2.5 million expense, which is our deductible under these insurance programs. There was limited impact on revenue in Q2 and the affected customers have turned replenishment orders back on in Q3. Adjusted loss from continuing operation was $3 million compared to $3.3 million of income in the prior year period. Adjusted EBITDA as reported decreased 9.8% to $20.2 million and was up 50 basis points as a percent of consolidated revenue to 9.7%. As a reminder, last year's adjusted EBITDA included a $2.4 million contribution from the divested Sunflower business. On an apples-to-apples basis, this quarter's EBITDA is flat to last year's. PTM EBITDA is $89.4 million, up $25 million or 39% versus the prior 12-month period. Turning to the balance sheet and cash flow, at the end of Q2, total debt was $336 million, with leverage of 3.7 times, in line with our target leverage of two to four times. We continue to expect to be within that range at year end 2023. Cash provided by operating activities during the second quarter of 2023 was a strong $16 million compared to cash used in operating activities of $2 million in the prior year. This improvement reflects the effective management of working capital and inventory in particular. Cash used in investing activities was $8 million compared to $34 million last year. The step down in capital expenditures was expected, reflecting the completion of our Midlothian, Texas plant. There are no huge projects on the near-term horizon and CapEx will continue to moderate. Let me close with comments on our outlook recognizing the environment remains very fluid. From a guidance standpoint, we are revising our 2023 estimates that were first provided on our Q4 call. We now expect revenue in the range of $880 million to $900 million. For the second half of 2023, the revisions are attributable to one, category softness and track channels; two, increased competition in frozen fruit and broth; and three, the timing of new business in plant-based. This outlook, excluding the divested Sunflower business, results in the plant-based segment growing in the high single-digits in the second half of 2023 with core packaged plant-based milks growing low double-digits, partially offset by headwinds in broth and ingredients. From a profit perspective, we expect adjusted EBITDA of $87 million to $91 million. From a pacing standpoint, for the total company, we would expect Q4 to be stronger than Q3. Finally, we would expect approximately $2 million to $4 million in startup costs in the second half with the majority occurring in Q3. For conservativeness, we have assumed that the three headwinds remain in the second half of 2023. However, we have the opportunity to deliver better results from category improvement, along with the possibility for a steeper ramp-up in production in Texas and in fruit snacks and for their productivity efforts. From a balance sheet and cash flow standpoint, we continue to expect capital expenditures on the cash flow statement of approximately $45 million. Consistent with this, we expect unlevered free cash flow in the $25 million to $35 million range. Before opening the call for questions, just a reminder that for competitive reasons we do not provide detailed commentary regarding customer or SKU level activity. And with that, operator, please open up the call for questions.